CH
Chandrashekar Hallikeri Basappa
About Chandrashekar Hallikeri Basappa
Data last updated:
Chandrashekar Hallikeri Basappa is an Additional Director at Concord Clinical And Translational Resource Private Limited (since 2023) and Director at Gokshadri Developers Private Limited (since 2025). The companies operate in Printing & Publishing and Real Estate. The largest current company by reported revenue is Concord Clinical And Translational Resource Private Limited at ₹2.5 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 28 Nov 2023 | 2017 | ₹2.5 Lakh (FY 2022) | Active | |
| Director | 11 Jun 2025 | 2025 | Active |
Board colleagues of Chandrashekar Hallikeri Basappa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nagarajan Sukumar | 10414960 | Concord Clinical And Translational Resource Private Limited | Additional Director |
| Shanthkumar Jettur | 11150039 | Gokshadri Developers Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandrashekar Hallikeri Basappa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandrashekar Hallikeri Basappa
Chandrashekar Hallikeri Basappa currently holds 2 directorships: Concord Clinical And Translational Resource Private Limited (Additional Director, since 28 Nov 2023, revenue ₹2.5 Lakh (FY 2022)); Gokshadri Developers Private Limited (Director, since 11 Jun 2025).
Chandrashekar Hallikeri Basappa was first appointed on 28 Nov 2023 as Additional Director at Concord Clinical And Translational Resource Private Limited. The most recent appointment on record is 11 Jun 2025 at Gokshadri Developers Private Limited.
The current boards of Chandrashekar Hallikeri Basappa's companies include Nagarajan Sukumar (Concord Clinical And Translational Resource Private Limited), Shanthkumar Jettur (Gokshadri Developers Private Limited).